These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9328577)

  • 21. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
    Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
    Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres.
    Pecquet S; Leo E; Fritsché R; Pfeifer A; Couvreur P; Fattal E
    Vaccine; 2000 Jan; 18(13):1196-202. PubMed ID: 10649620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara.
    Sharpe S; Hanke T; Tinsley-Bown A; Dennis M; Dowall S; McMichael A; Cranage M
    Virology; 2003 Aug; 313(1):13-21. PubMed ID: 12951017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection.
    Beauverger P; Cardoso AI; Daviet L; Buckland R; Wild TF
    Virology; 1996 May; 219(1):133-9. PubMed ID: 8623522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
    Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
    Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell priming versus T cell tolerance induced by synthetic peptides.
    Aichele P; Brduscha-Riem K; Zinkernagel RM; Hengartner H; Pircher H
    J Exp Med; 1995 Jul; 182(1):261-6. PubMed ID: 7540654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Pharm Res; 2004 Jan; 21(1):121-6. PubMed ID: 14984266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines.
    Ertl HC; Varga I; Xiang ZQ; Kaiser K; Stephens L; Otvos L
    Vaccine; 1996 Jun; 14(9):879-85. PubMed ID: 8843629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.
    Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL
    Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
    Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
    J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers.
    Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M
    Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.
    Mossman SP; Evans LS; Fang H; Staas J; Tice T; Raychaudhuri S; Grabstein KH; Cheever MA; Johnson ME
    Vaccine; 2005 May; 23(27):3545-54. PubMed ID: 15855013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Pecquet S; Fattal E; Trollé S; Chachaty E; Couvreur P; Andremont A
    Infect Immun; 1997 Mar; 65(3):853-7. PubMed ID: 9038287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein.
    Etchart N; Desmoulins PO; Chemin K; Maliszewski C; Dubois B; Wild F; Kaiserlian D
    J Immunol; 2001 Jul; 167(1):384-91. PubMed ID: 11418674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres.
    Barman SP; Lunsford L; Chambers P; Hedley ML
    J Control Release; 2000 Dec; 69(3):337-44. PubMed ID: 11102674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.
    Layton GT; Harris SJ; Myhan J; West D; Gotch F; Hill-Perkins M; Cole JS; Meyers N; Woodrow S; French TJ; Adams SE; Kingsman AJ
    Immunology; 1996 Feb; 87(2):171-8. PubMed ID: 8698376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine.
    Singh M; McGee JP; Li XM; Koff W; Zamb T; Wang CY; O'Hagan DT
    J Pharm Sci; 1997 Nov; 86(11):1229-33. PubMed ID: 9383731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.